Cargando…

Present and Future: Pharmacologic Treatment of Obesity

Obesity now presents one of the biggest health problems of our times. Diet and exercise are best for both prevention and treatment; unfortunately, both require much discipline and are difficult to maintain. Medications offer a possible adjunct, but their effect is modest, they are limited by side ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Glandt, Mariela, Raz, Itamar
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038640/
https://www.ncbi.nlm.nih.gov/pubmed/21331293
http://dx.doi.org/10.1155/2011/636181
_version_ 1782198119153270784
author Glandt, Mariela
Raz, Itamar
author_facet Glandt, Mariela
Raz, Itamar
author_sort Glandt, Mariela
collection PubMed
description Obesity now presents one of the biggest health problems of our times. Diet and exercise are best for both prevention and treatment; unfortunately, both require much discipline and are difficult to maintain. Medications offer a possible adjunct, but their effect is modest, they are limited by side effects, and the weight loss lasts only as long as the drug is being taken, since as soon as treatment is stopped, the weight is regained. Sibutramine, a sympathomimetic medication which was available for long-term treatment, is the most recent of the drugs to be withdrawn from the market due to side effects; in this case it was an increased risk of cardiovascular events. This paper reviews those medications which are available for treatment of obesity, including many of those recently taken off the market. It also discusses some of the newer treatments that are currently being investigated.
format Text
id pubmed-3038640
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30386402011-02-17 Present and Future: Pharmacologic Treatment of Obesity Glandt, Mariela Raz, Itamar J Obes Review Article Obesity now presents one of the biggest health problems of our times. Diet and exercise are best for both prevention and treatment; unfortunately, both require much discipline and are difficult to maintain. Medications offer a possible adjunct, but their effect is modest, they are limited by side effects, and the weight loss lasts only as long as the drug is being taken, since as soon as treatment is stopped, the weight is regained. Sibutramine, a sympathomimetic medication which was available for long-term treatment, is the most recent of the drugs to be withdrawn from the market due to side effects; in this case it was an increased risk of cardiovascular events. This paper reviews those medications which are available for treatment of obesity, including many of those recently taken off the market. It also discusses some of the newer treatments that are currently being investigated. Hindawi Publishing Corporation 2011 2011-02-08 /pmc/articles/PMC3038640/ /pubmed/21331293 http://dx.doi.org/10.1155/2011/636181 Text en Copyright © 2011 M. Glandt and I. Raz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Glandt, Mariela
Raz, Itamar
Present and Future: Pharmacologic Treatment of Obesity
title Present and Future: Pharmacologic Treatment of Obesity
title_full Present and Future: Pharmacologic Treatment of Obesity
title_fullStr Present and Future: Pharmacologic Treatment of Obesity
title_full_unstemmed Present and Future: Pharmacologic Treatment of Obesity
title_short Present and Future: Pharmacologic Treatment of Obesity
title_sort present and future: pharmacologic treatment of obesity
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038640/
https://www.ncbi.nlm.nih.gov/pubmed/21331293
http://dx.doi.org/10.1155/2011/636181
work_keys_str_mv AT glandtmariela presentandfuturepharmacologictreatmentofobesity
AT razitamar presentandfuturepharmacologictreatmentofobesity